Usefulness of Triglycerides-to-High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men

American Journal of Cardiology

Volumn 104, Issue 10, 2009, Pages 1393-1397

  Cordero, Alberto ^a   Andrés, Eva ^b   Ordoñez, Beatriz ^b   León, Montserrat ^b   Laclaustra, Martín ^c   Grima, Alberto ^d   Luengo, Emilio ^b   Moreno, José ^a   Bes, María ^b   Pascual, Isaac ^b   Civeira, Fernando ^b   Pocoví, Miguel ^b   Alegría, Eduardo ^d   Casasnovas, José A ^b  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d Asepeyo ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS; WORKER;

ADULT; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; OBESITY; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 71749105342     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.07.008     Document Type: Article

References (29)

1. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., Bonadonna R.C., and Muggeo M. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53 (2004) 1782-1789
2. de Simone G., Devereux R.B., Chinali M., Roman M.J., Best L.G., Welty T.K., Lee E.T., and Howard B.V. Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study. Hypertension 47 (2006) 162-167
3. Kumanyika S.K., Obarzanek E., Stettler N., Bell R., Field A.E., Fortmann S.P., Franklin B.A., Gillman M.W., Lewis C.E., Poston W.C., Stevens J., and Hong Y. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association council on epidemiology and prevention, interdisciplinary committee for prevention (formerly the expert panel on population and prevention science). Circulation 118 (2008) 428-464
4. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., van der Schouw Y.T., Spencer E., Moons K.G., Tjonneland A., Halkjaer J., Jensen M.K., Stegger J., Clavel-Chapelon F., Boutron-Ruault M.C., Chajes V., Linseisen J., Kaaks R., Trichopoulou A., Trichopoulos D., Bamia C., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Peeters P.H., May A.M., Bueno-de-Mesquita H.B., van Duijnhoven F.J., Hallmans G., Weinehall L., Manjer J., Hedblad B., Lund E., Agudo A., Arriola L., Barricarte A., Navarro C., Martinez C., Quiros J.R., Key T., Bingham S., Khaw K.T., Boffetta P., Jenab M., Ferrari P., and Riboli E. General and abdominal adiposity and risk of death in Europe. N Engl J Med 359 (2008) 2105-2120
5. Cordero A., Laclaustra M., Leon M., Casasnovas J.A., Grima A., Luengo E., Ordonez B., Bergua C., Bes M., Pascual I., and Alegria E. Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am J Cardiol 102 (2008) 424-428
6. Cordero A., Leon M., Andres E., Ordonez B., Laclaustra M., Grima A., Pascual I., Luengo E., Civeira F., Pocovi M., Alegria E., and Casasnovas J.A. Gender differences in obesity related cardiovascular risk factors in Spain. Prev Med 48 (2009) 134-139
7. Diercks D.B., Roe M.T., Mulgund J., Pollack C.V., Kirk J.D., Gibler W.B., Ohman E.M., Smith S.C., Boden W.E., and Peterson E.D. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the American College of Cardiology/American Heart Association guidelines quality improvement initiative. Am Heart J 152 (2006) 140-148
8. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas R.J., Allison T.G., Mookadam F., and Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
9. Uretsky S., Messerli F.H., Bangalore S., Champion A., Cooper-Dehoff R.M., Zhou Q., and Pepine C.J. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 120 (2007) 863-870
10. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., Lang C.C., Rumboldt Z., Onen C.L., Lisheng L., Tanomsup S., Wangai P., Razak F., Sharma A.M., and Anand S.S. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
11. Gelber R.P., Gaziano J.M., Orav E.J., Manson J.E., Buring J.E., and Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52 (2008) 605-615
12. Zeller M., Steg P.G., Ravisy J., Lorgis L., Laurent Y., Sicard P., Janin-Manificat L., Beer J.C., Makki H., Lagrost A.C., Rochette L., and Cottin Y. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 118 (2008) 482-490
13. Schulte H., Cullen P., and Assmann G. Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM). Atherosclerosis 144 (1999) 199-209
14. Alegria E., Cordero A., Laclaustra M., Grima A., Leon M., Casasnovas J.A., Luengo E., Del Rio A., and Ferreira I. Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev Esp Cardiol 58 (2005) 797-806
15. Cordero A., Laclaustra M., Leon M., Grima A., Casasnovas J.A., Luengo E., Del Rio A., Ferreira I., and Alegria E. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) registry substudy. Am J Hypertens 19 (2006) 189-196
16. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., Pasternak R.C., Smith Jr. S.C., and Stone N.J. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
17. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., Bergeron J., Gaudet D., Tremblay G., Prud'Homme D., Nadeau A., and Despres J.P. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 102 (2000) 179-184
18. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
19. Ghandehari H., Kamal-Bahl S., and Wong N.D. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J 156 (2008) 112-119
20. Despres J.P., Lemieux I., Dagenais G.R., Cantin B., and Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 153 (2000) 263-272
21. deGoma E.M., Leeper N.J., and Heidenreich P.A. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol 51 (2008) 49-55
22. Gaziano J.M., Hennekens C.H., O'Donnell C.J., Breslow J.L., and Buring J.E. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96 (1997) 2520-2525
23. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
24. Rutter M.K., Wilson P.W., Sullivan L.M., Fox C.S., D'Agostino Sr. R.B., and Meigs J.B. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 117 (2008) 1003-1009
25. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., and Montori V.M. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 (2007) 403-414
26. Hanak V., Munoz J., Teague J., Stanley A., and Bittner V. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol 94 (2004) 219-222
27. Koba S., Hirano T., Ito Y., Tsunoda F., Yokota Y., Ban Y., Iso Y., Suzuki H., and Katagiri T. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis 189 (2006) 206-214
28. Barter P., Gotto A.M., LaRosa J.C., Maroni J., Szarek M., Grundy S.M., Kastelein J.J., Bittner V., and Fruchart J.C. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357 (2007) 1301-1310
29. Madala M.C., Franklin B.A., Chen A.Y., Berman A.D., Roe M.T., Peterson E.D., Ohman E.M., Smith Jr. S.C., Gibler W.B., and McCullough P.A. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 52 (2008) 979-985